Page breadcrumb nav

VAERS Report 2156928

Case Report Section

Détails du rapport Vaer

Âge: 12 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: fm3092


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-26
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

nausea; fever; chills; arm pain at vaccination site; dose 1: 03nov2021 and dose 2: 26feb2022; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory authority (ra). regulatory number: gb-mhra-webcovid-202202270801318190-es8sa. other case identifier(s): gb-mhra-adr 26657087. a 12 year-old female patient received bnt162b2 (comirnaty), administration date 26feb2022 (lot number: fm3092) at the age of 12 years as dose 2, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. vaccination history included: comirnaty (dose 1, single; lot number: unknown), administration date: 03nov2021, for covid-19 immunisation. the following information was reported: nausea (medically significant) with onset 26feb2022, outcome "recovering", described as "nausea"; pyrexia (medically significant) with onset 26feb2022, outcome "not recovered", described as "fever"; chills (medically significant) with onset 26feb2022, outcome "recovering", described as "chills"; vaccination site pain (medically significant) with onset 26feb2022, outcome "unknown", described as "arm pain at vaccination site"; inappropriate schedule of product administration (non-serious) with onset 26feb2022, outcome "unknown", described as "dose 1: 03nov2021 and dose 2: 26feb2022". the clinical course was reported as follows: the patient had arm pain at vaccination site occurred from an hour after vaccination. nausea, fever and chills occurred about 12-14 hours after vaccination. the patient had no symptoms associated with covid-19 and did not undergo a covid-19 test. the patient was not enrolled in clinical trial. the patient was not tested positive for covid-19 since the vaccination. the report of the patient was not related to possible inflammation of the heart (myocarditis or pericarditis). no follow-up attempts are possible. no further information is expected

Données de laboratoire
na
Liste des symptômes
chills nausea pyrexia inappropriate schedule of product administration vaccination site pain
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na